Canopy Network has announced it is launching Canopy Templates, a new blockchain building tool designed to aid in AI-assisted development.

Elizabeth is a contributor to CNET and the The Simple Dollar, where she reviews insurance providers and policies. She has more than three years of experience writing for top online insurance and ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

ExtenZe has not been proven to work for erectile dysfunction. Many of ExtenZe's ingredients have no safety or effectiveness studies in humans. The company behind ExtenZe was fined for false ...

The 2026 World Cup is fast approaching. It’s almost Christmas (can you believe it?), and before long we’ll be in 2026—meaning we’re just months away from the largest World Cup in history, hosted ...

Business Insider asked etiquette experts about the mistakes to avoid when attending a work event. Showing up dressed inappropriately and not greeting members of leadership are major faux pas. Hiding ...

Good morning. Welcome to the Jefferies London Healthcare Conference. My name is Dennis Ding, biotech analyst here at Jefferies. I have the wonderful pleasure of having Recursion Pharmaceuticals up ...

States are banning cellphones in schools, but do these policies actually work to improve student behavior and achievement? A pair of research projects led by noted academic scholars provide some ...

PENNSYLVANIA, USA — Have a favorite shirt or sweater that looks old and worn? Now there is a product that claims you can make it look new again with the Smooth It lint shaver, but Does It Really Work?

In summer 2019, Bob McDonough took a full stack web development coding bootcamp at the University of Pennsylvania. An English-turned-telecommunications major in college, McDonough had been working at ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...